Calidi Biotherapeutics Balance Sheet (2021-2026)

Reported Financials

Calidi Biotherapeutics Quarterly Balance Sheet

Periods 18 quarters

Latest Jun 2026

Calidi Biotherapeutics reported total assets of $0.01B and total liabilities of $0.00B for the quarter ended Jun 2026, down 52.2% year over year. This balance sheet covers 18 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.					0.00B			0.01B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Cash & Current Investments					0.00B			0.01B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Receivables - NetNet Receivables					870.00		870.00
Receivables - OtherOther Receivables					0.00B	870.00			0.00B		0.00B		0.00B	0.00B	0.00B		50.00B
Receivables					0.00B		870.00
Prepaid Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Current Assets	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)													0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Long-Term Investments	0.23B	0.23B	0.23B	0.04B	0.04B	0.04B	0.04B	0.00B	0.00B
Other Non-Current Assets	0.00B	0.00B	0.00B		0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Non-Current Assets	0.23B	0.23B	0.23B	0.04B	0.04B	0.04B	0.04B	0.01B	0.01B	0.01B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Assets	0.23B	0.23B	0.23B	0.04B	0.00B	0.04B	0.04B	0.02B	0.01B	0.01B	0.00B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B
Liabilities
Current Liabilities
Accounts Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Notes Payables				0.00B	0.00B	0.00B	0.00B			0.00B
Payables	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Accumulated Expenses	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Accumulated Expenses										0.00B	0.00B	0.00B	0.00B
Short term Debt					0.00B			0.00B		0.00B	0.00B	0.00B	0.00B
Current Leases				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Total Current Liabilities	0.00B	0.00B	0.00B	0.00B	0.04B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B
Non-Current Liabilities
Capital Leases				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Non-Current Debt					0.00B			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.50B	0.00B	0.00B
Convertible Debt										0.00B	0.00B	0.00B
Non-Current Deffered Revenue	0.01B	0.01B	0.01B	0.01B	0.01B
Preferred Stock Liabilities	0.23B	0.23B	0.23B	0.04B	0.04B	0.04B	0.04B
Minority Interest												0.00B	0.00B	0.00B	0.00B	0.00B
Operating Leases				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Other Non-Current Liabilities	0.01B	0.01B	0.00B	0.00B	0.03B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Total Non-Current Liabilities	0.02B	0.01B	0.01B	0.01B	0.00B	0.00B	0.00B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.00B	0.00B
Total Liabilities	0.02B	0.01B	0.01B	0.01B	0.04B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B
Shareholder's Equity
Total Debt				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.50B	0.00B	0.00B
Common Equity	-0.03B	-0.04B	-0.04B	-0.04B	-0.05B	-0.06B	-0.06B	-0.00B	-0.01B	-0.01B	-0.01B	-0.01B	0.00B	0.01B	0.00B	0.01B	0.00B	0.00B
Liabilities and Shareholders Equity	0.23B	0.23B	0.23B	0.04B	0.00B	0.04B	0.04B	0.02B	0.01B	0.01B	0.00B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B
Retained Earnings	-0.01B	-0.01B	-0.01B	-0.01B	-0.07B	-0.01B	-0.01B	-0.09B	-0.10B	-0.11B	-0.11B	-0.12B	0.12B	0.13B	0.13B	0.14B	0.15B	0.15B
Treasury Shares	0.02B	0.02B	0.02B	0.00B	0.01B	0.00B	0.00B

Calidi Biotherapeutics CLDI Balance Sheet (2021-2026)

Calidi Biotherapeutics Quarterly Balance Sheet

Create an account

Sign In

Reset Password